[Emergency Pod] Peptides - Part 2 with Dr. Jonathan Slotkin of Scrub Capital

In this special episode of Lifers, Christina Farr sits down with Dr. Jonathan Slotkin (neurosurgeon, CMO, and co-founder of Scrub Capital) for a timely conversation on peptides and what the latest HHS announcements mean for patients and the longevity industry. Jon breaks down his own protocol, makes the case that the longevity conversation has too often left women out, and closes with a watch-out for investors: the potential descheduling of testosterone.

—
SPONSOR: Granola

Granola AI, The AI notepad for people in back-to-back meetings: https://granola.ai/lifers with code: LIFERS

Interested in sponsoring the show? [email protected]

—
LINKS:
Scrub Capital: https://scrubcapital.com/ 
Ashley Winter on Twitter: https://x.com/AshleyGWinter 
Peptide Reclassification: https://peptide-db.com/guides/fda-peptide-reclassification-2026 
Testosterone/TRT expansion: https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men 

Chrissy Farr on YouTube: https://www.youtube.com/@LiferswithChristinaFarr 
Chrissy Farr on Instagram: https://www.instagram.com/cfarr/ 
Subscribe to the Second Opinion Newsletter: https://secondopinion.media/ 
Chrissy’s Book: The Storyteller's Advantage: https://www.chrissyfarr.com/books 

—
FOLLOW:
Jon:
https://www.linkedin.com/in/slotkinjr 
https://x.com/slotkinjr 

Christina Farr:
https://www.linkedin.com/in/christinafarr/ 
https://x.com/chrissyfarr 

—
TIMESTAMPS:
(00:00) Intro
(01:08) What are peptides
(02:25) Safety and FDA nuance
(04:53) Clinician survey tribes
(07:15) Jon’s personal protocol
(10:03) Women and hormone gaps
(14:08) Sponsor: Granola
(14:47) Why peptides are everywhere
(17:11) Finding the right provider
(20:47) Follow John and final nugget
(21:49) Testosterone descheduling watch
(22:31) Wrap